Well it don't think it will be 10 years but it'll be longer than 2. The FDA has yet to approve a pivotal trial which hasn't yet been designed or the funding organised.
I'm guessing it will require 15-20 patients with maybe a 12 month follow up. But there could well be interim reports of progress and you never know when a partner might get interested.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-30
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M | |||
| Open | High | Low | Value | Volume |
| $14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.95 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |